Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue Estimates

Armata Pharmaceuticals, Inc. (ARMP) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of$ 0.38. This compares to loss of $0.69 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 47.37%. A quarter ago, it was expected that this company would post a loss of$ 0.35 per share when it actually produced a loss of $0.23, delivering a surprise of 34.29%.Over the last four quarters, the company ...